Guidance

MERS-CoV: presumptive positive sample referral pathway

How to refer presumptive positive Middle East respiratory syndrome coronavirus (MERS-CoV) samples to the National Reference Laboratory.

Document

Referral of presumptive positive Middle East respiratory syndrome coronavirus (MERS-CoV) samples to the National Reference Laboratory

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This document provides advice for diagnostic laboratories on:

  • primary testing and confirmatory testing arrangements for MERS-CoV in England
  • how to request confirmatory testing and how to send samples to the Respiratory Virus Unit
  • required public health actions
  • actions to take for non-MERS coronavirus results
  • referral of further specimens from confirmed MERS cases
  • recommendations for non-PHE clinical diagnostic laboratories considering provision of MERS-CoV testing in England
Published 26 August 2014
Last updated 30 June 2017 + show all updates
  1. Updated document.
  2. Updated with August 2016 publication.
  3. Added 2 labs to the referral pathway: Leeds and Manchester.
  4. Updated to include Edinburgh on the list of PHE public health laboratory and the devolved administration laboratories.
  5. Updated version (April 2015) of referral pathway.
  6. First published.